CATSmart is Fresenius Kabi’s next-generation continuous autotransfusion system, which helps reduce blood loss during surgery. CATSmart will be distributed in the U.S. by Terumo Cardiovascular Group. Fresenius Kabi USA and Terumo Cardiovascular Group have signed an exclusive, five-year distribution agreement for CATSmart.

Tigecycline, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

Bivalirudin for Injection, a direct thrombin inhibitor, expands the company's anticoagulant portfolio.

A website published by Fresenius Kabi Germany on nutritional therapies for different types of patients has won the Health Media Award. The jury praised www.ernaehrungstherapie-hilft.de for its comprehensive information, a user-friendly presentation, and the site's attractive interactive elements. The German-language site targets not only patients and their family members, but also physicians, nutritionists and caregivers.

Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug, is now available in the company’s Simplist™ ready-to-administer prefilled syringe in the United States. This marks the first new product launch for the Simplist™ line following ownership by Fresenius Kabi.

Daptomycin, an antibiotic, expands Fresenius Kabi's anti-infective Portfolio.

Fresenius Kabi is expanding its Melrose Park, Illinois site to significantly increase capacity for the production of injectable generic pharmaceuticals. The multi-stage expansion at the facility, just outside of Chicago, will include construction of a number of new buildings. Completion is scheduled for 2026, following an investment of nearly $250 million. www.fresenius-kabi.us

The emergency response and global health organization AmeriCares has presented its Power of Partnership Award to Fresenius Kabi USA. The annual award recognizes the company’s commitment to helping disaster survivors and improving health care access around the world. Fresenius Kabi has backed AmeriCares since 2010. The company has supported more than 400 volunteer medical outreach trips and donated enough medicine to fill more than 350,000 prescriptions for patients in need worldwide.

Chloramphenicol Sodium Succinate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

Linezolid injection further expands the Fresenius Kabi anti-infective portfolio. It is available in the company's proprietary Freeflex® bag.